Research progress of microfluidic chips in age-related macular degeneration
Age-related macular degeneration(ARMD)is the primary cause of severe visual impairment and blindness in people over 60 years old. With the aging of the global population, the incidence of the disease is also rising year by year. However, the pathogenesis and treatment strategy of ARMD need to be fur...
Main Authors: | Bi-Qian Lin, Dong-Cheng Liu, Bo Qin |
---|---|
Format: | Article |
Language: | English |
Published: |
Press of International Journal of Ophthalmology (IJO PRESS)
2023-11-01
|
Series: | Guoji Yanke Zazhi |
Subjects: | |
Online Access: | http://ies.ijo.cn/cn_publish/2023/11/202311012.pdf |
Similar Items
-
Paper-Based Microfluidic Platforms for Understanding the Role of Exosomes in the Pathogenesis of Major Blindness-Threatening Diseases
by: Min-Yen Hsu, et al.
Published: (2018-05-01) -
Research progress on risk factors of age-related macular degeneration
by: Jin-Shou Yang, et al.
Published: (2021-09-01) -
Progress of Aflibercept of clinical application for neovascular age-related macular degeneration
by: Yun-Yan Zheng, et al.
Published: (2021-10-01) -
Progress in animal models of age-related macular degeneration
by: Tong-Miao Wang, et al.
Published: (2019-04-01) -
Recent Advances in Age-Related Macular Degeneration Therapies
by: Marie Fabre, et al.
Published: (2022-08-01)